Conclusion:
To the best of our knowledge, this is the first report of methemoglobinemia induced by a high dose of SMX/TMP in pediatric patients occurring within three days which may indicate methemoglobinemia due to SMX/TMP as a dose-related side effect. Observation and rapid management are recommended.